178 related articles for article (PubMed ID: 15716060)
41. Attenuation of recombinant vesicular stomatitis viruses encoding mutant glycoproteins demonstrate a critical role for maintaining a high pH threshold for membrane fusion in viral fitness.
Fredericksen BL; Whitt MA
Virology; 1998 Jan; 240(2):349-58. PubMed ID: 9454708
[TBL] [Abstract][Full Text] [Related]
42. Purification and in vitro-phospholabeling of secretory envelope proteins E1 and E2 of hepatitis C virus expressed in insect cells.
Hüssy P; Schmid G; Mous J; Jacobsen H
Virus Res; 1996 Nov; 45(1):45-57. PubMed ID: 8896240
[TBL] [Abstract][Full Text] [Related]
43. Rapid adaptation of a recombinant vesicular stomatitis virus to a targeted cell line.
Gao Y; Whitaker-Dowling P; Watkins SC; Griffin JA; Bergman I
J Virol; 2006 Sep; 80(17):8603-12. PubMed ID: 16912309
[TBL] [Abstract][Full Text] [Related]
44. Mechanism of formation of pseudotypes between vesicular stomatitis virus and murine leukemia virus.
Witte ON; Baltimore D
Cell; 1977 Jul; 11(3):505-11. PubMed ID: 195740
[TBL] [Abstract][Full Text] [Related]
45. Assembly of HCV E1 and E2 glycoproteins into coronavirus VLPs.
Jourdan N; Godeke GJ; Penaud M; Mottola G; Sorrentino A; Rottier PJ; Bonatti S
Arch Virol; 2006 Oct; 151(10):2085-94. PubMed ID: 16648962
[TBL] [Abstract][Full Text] [Related]
46. Expression and processing of hepatitis C virus structural proteins in Pichia pastoris yeast.
Martinez-Donato G; Acosta-Rivero N; Morales-Grillo J; Musacchio A; Vina A; Alvarez C; Figueroa N; Guerra I; Garcia J; Varas L; Muzio V; Dueñas-Carrera S
Biochem Biophys Res Commun; 2006 Apr; 342(2):625-31. PubMed ID: 16488393
[TBL] [Abstract][Full Text] [Related]
47. Expression of hepatitis C virus envelope proteins in transgenic mice.
Koike K; Moriya K; Ishibashi K; Matsuura Y; Suzuki T; Saito I; Iino S; Kurokawa K; Miyamura T
J Gen Virol; 1995 Dec; 76 ( Pt 12)():3031-8. PubMed ID: 8847508
[TBL] [Abstract][Full Text] [Related]
48. Functional hepatitis C virus envelope glycoproteins.
Voisset C; Dubuisson J
Biol Cell; 2004 Aug; 96(6):413-20. PubMed ID: 15325070
[TBL] [Abstract][Full Text] [Related]
49. A vesicular stomatitis pseudovirus expressing the surface glycoproteins of influenza A virus.
Cheresiz SV; Kononova AA; Razumova YV; Dubich TS; Chepurnov AA; Kushch AA; Davey R; Pokrovsky AG
Arch Virol; 2014 Oct; 159(10):2651-8. PubMed ID: 24888312
[TBL] [Abstract][Full Text] [Related]
50. Characterization of the structural proteins of hepatitis C virus expressed by an adenovirus recombinant.
Seong YR; Lee CH; Im DS
Virus Res; 1998 Jun; 55(2):177-85. PubMed ID: 9725670
[TBL] [Abstract][Full Text] [Related]
51. Hepatitis C virus envelope proteins bind lactoferrin.
Yi M; Kaneko S; Yu DY; Murakami S
J Virol; 1997 Aug; 71(8):5997-6002. PubMed ID: 9223490
[TBL] [Abstract][Full Text] [Related]
52. Lymphocytic choriomeningitis virus. VIII. Reciprocal formation of pseudotypes with vesicular stomatitis virus.
Bruns M; Lehmann-Grube F
Virology; 1984 Aug; 137(1):49-57. PubMed ID: 6089420
[TBL] [Abstract][Full Text] [Related]
53. Delayed appearance of pseudotypes between vesicular stomatitis virus influenza virus during mixed infection of MDCK cells.
Roth MG; Compans RW
J Virol; 1981 Dec; 40(3):848-60. PubMed ID: 6275120
[TBL] [Abstract][Full Text] [Related]
54. Characterization of truncated forms of hepatitis C virus glycoproteins.
Michalak JP; Wychowski C; Choukhi A; Meunier JC; Ung S; Rice CM; Dubuisson J
J Gen Virol; 1997 Sep; 78 ( Pt 9)():2299-306. PubMed ID: 9292018
[TBL] [Abstract][Full Text] [Related]
55. Neutralization of pseudotyped vesicular stomatitis virus expressing hepatitis C virus envelope glycoprotein 1 or 2 by serum from patients.
Lagging LM; Meyer K; Westin J; Wejstål R; Norkrans G; Lindh M; Ray R
J Infect Dis; 2002 Apr; 185(8):1165-9. PubMed ID: 11930327
[TBL] [Abstract][Full Text] [Related]
56. Tandem repeats of lactoferrin-derived anti-hepatitis C virus peptide enhance antiviral activity in cultured human hepatocytes.
Abe K; Nozaki A; Tamura K; Ikeda M; Naka K; Dansako H; Hoshino HO; Tanaka K; Kato N
Microbiol Immunol; 2007; 51(1):117-25. PubMed ID: 17237607
[TBL] [Abstract][Full Text] [Related]
57. Delineation of regions important for heteromeric association of hepatitis C virus E1 and E2.
Yi M; Nakamoto Y; Kaneko S; Yamashita T; Murakami S
Virology; 1997 Apr; 231(1):119-29. PubMed ID: 9143310
[TBL] [Abstract][Full Text] [Related]
58. Role of N-linked glycans in the interactions of recombinant HCV envelope glycoproteins with cellular receptors.
Chen PC; Chuang PK; Chen CH; Chan YT; Chen JR; Lin SW; Ma C; Hsu TL; Wong CH
ACS Chem Biol; 2014 Jul; 9(7):1437-43. PubMed ID: 24766301
[TBL] [Abstract][Full Text] [Related]
59. Hepatitis C virus envelope glycoproteins and potential for vaccine development.
Beyene A; Basu A; Meyer K; Ray R
Vox Sang; 2002 Aug; 83 Suppl 1():27-32. PubMed ID: 12617098
[TBL] [Abstract][Full Text] [Related]
60. Processing of E1 and E2 glycoproteins of hepatitis C virus expressed in mammalian and insect cells.
Matsuura Y; Suzuki T; Suzuki R; Sato M; Aizaki H; Saito I; Miyamura T
Virology; 1994 Nov; 205(1):141-50. PubMed ID: 7975209
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
